These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 8368149

  • 21. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
    de Kroon JF, de Paus RA, Kluin-Nelemans HC, Kluin PM, van Bergen CA, Munro AJ, Hale G, Willemze R, Falkenburg JH.
    Exp Hematol; 1996 Jul; 24(8):919-26. PubMed ID: 8690051
    [Abstract] [Full Text] [Related]

  • 22. Tk, a new colon tumor-associated antigen resulting from altered O-glycosylation.
    Meichenin M, Rocher J, Galanina O, Bovin N, Nifantev N, Sherman A, Cassagnau E, Heymann MF, Bara J, Fraser RH, Le Pendu J.
    Cancer Res; 2000 Oct 01; 60(19):5499-507. PubMed ID: 11034094
    [Abstract] [Full Text] [Related]

  • 23. Application of monoclonal antibodies to tumor diagnosis and therapy.
    Rosen ST, Winter JN, Epstein AL.
    Ann Clin Lab Sci; 1983 Oct 01; 13(3):173-84. PubMed ID: 6347022
    [Abstract] [Full Text] [Related]

  • 24. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
    de Muralt B, de Tribolet N, Diserens AC, Carrel S, Mach JP.
    Anticancer Res; 1983 Oct 01; 3(1):1-6. PubMed ID: 6830147
    [Abstract] [Full Text] [Related]

  • 25. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U, Köhler S, Prietl G, Giffels P, Schmidt-Nicolai S, Schlebusch H, Grünn U, Bender H, Biersack HJ, De Potter C, Krebs D, Wallwiener D.
    Zentralbl Gynakol; 1999 Oct 01; 121(4):190-5. PubMed ID: 10355096
    [Abstract] [Full Text] [Related]

  • 26. Tumor antigens in astrocytic gliomas.
    Kurpad SN, Zhao XG, Wikstrand CJ, Batra SK, McLendon RE, Bigner DD.
    Glia; 1995 Nov 01; 15(3):244-56. PubMed ID: 8586461
    [Abstract] [Full Text] [Related]

  • 27. A mutant chaperone converts a wild-type protein into a tumor-specific antigen.
    Schietinger A, Philip M, Yoshida BA, Azadi P, Liu H, Meredith SC, Schreiber H.
    Science; 2006 Oct 13; 314(5797):304-8. PubMed ID: 17038624
    [Abstract] [Full Text] [Related]

  • 28. Active immunization of human cancer with tumor cell-associated carbohydrate antigen.
    Adachi M, Inui Y, Suzuki Y, Ietomi K, Orimo K, Kobayashi S, Joshita T, Arai T, Matsumoto J, Okano A.
    Anticancer Res; 1989 Oct 13; 9(2):309-12. PubMed ID: 2473694
    [Abstract] [Full Text] [Related]

  • 29. Glycoengineering of alphaGal xenoantigen on recombinant peptide bearing the J28 pancreatic oncofetal glycotope.
    Sadoulet MO, Franceschi C, Aubert M, Silvy F, Bernard JP, Lombardo D, Mas E.
    Glycobiology; 2007 Jun 13; 17(6):620-30. PubMed ID: 17374617
    [Abstract] [Full Text] [Related]

  • 30. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ, Hoffmann N, Farago M, Hoogenboom HR, Eisenbach L, Reiter Y.
    Cancer Res; 2002 Oct 15; 62(20):5835-44. PubMed ID: 12384546
    [Abstract] [Full Text] [Related]

  • 31. Developmentally regulated expression of metastasis-associated antigens in the rat.
    Claas C, Herrmann K, Matzku S, Möller P, Zöller M.
    Cell Growth Differ; 1996 May 15; 7(5):663-78. PubMed ID: 8732676
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells.
    Satoh M, Ito A, Nojiri H, Handa K, Numahata K, Ohyama C, Saito S, Hoshi S, Hakomori SI.
    Int J Oncol; 2001 Oct 15; 19(4):723-31. PubMed ID: 11562747
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Glycosphingolipid carriers of carbohydrate antigens of human myeloid cells recognized by monoclonal antibodies.
    Uemura K, Macher BA, DeGregorio M, Scudder P, Buehler J, Knapp W, Feizi T.
    Biochim Biophys Acta; 1985 Jul 30; 846(1):26-36. PubMed ID: 2410035
    [Abstract] [Full Text] [Related]

  • 37. Molecular changes in carbohydrate antigens associated with cancer.
    Singhal A, Hakomori S.
    Bioessays; 1990 May 30; 12(5):223-30. PubMed ID: 1695095
    [Abstract] [Full Text] [Related]

  • 38. Biosignals modulated by tumor-associated carbohydrate antigens: novel targets for cancer therapy.
    Furukawa K, Hamamura K, Aixinjueluo W, Furukawa K.
    Ann N Y Acad Sci; 2006 Nov 30; 1086():185-98. PubMed ID: 17185516
    [Abstract] [Full Text] [Related]

  • 39. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.
    Viloria-Petit A, Crombet T, Jothy S, Hicklin D, Bohlen P, Schlaeppi JM, Rak J, Kerbel RS.
    Cancer Res; 2001 Jul 01; 61(13):5090-101. PubMed ID: 11431346
    [Abstract] [Full Text] [Related]

  • 40. Immune selection in murine tumors. Ph.d thesis.
    Svane IM, Engel AM.
    APMIS Suppl; 2003 Jul 01; (106):1-46. PubMed ID: 12739251
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.